# Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices

> **NCT02361489** · PHASE4 · UNKNOWN · sponsor: **Valeritas, Inc.** · enrollment: 90 (estimated)

## Conditions studied

- Diabetes Type II

## Interventions

- **DEVICE:** V-Go

## Key facts

- **NCT ID:** NCT02361489
- **Lead sponsor:** Valeritas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2015-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361489, "Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02361489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*